Product Information
HYDROXYCHLOROQUINE 200 MG TAB is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.1545 per EA under NDC 16571011250. Its NADAC has been published 139 times since Nov 1, 2023.
Strength
200 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571011250
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
HYDROXYCHLOROQUINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA210959On Market Since
5/29/2023
Pharmacological Classes
Price Statistics
The NADAC for HYDROXYCHLOROQUINE 200 MG TAB has been published 139 times since Nov 1, 2023, and over the history we have for it it has declined 13.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1545 per EA |
|---|---|
| All-time high | $0.1956 (Feb 14, 2024) |
| All-time low | $0.1399 (Nov 20, 2024) |
| 52-week high | $0.1643 |
| 52-week low | $0.1545 |
| Median price | $0.1622 |
| Average price | $0.1661 |
| Largest weekly change | -20.5% (Nov 20, 2024) |
| Weeks tracked | 139 |
| Tracking since | Nov 1, 2023 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of HYDROXYCHLOROQUINE 200 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for HYDROXYCHLOROQUINE 200 MG TAB, manufactured by Rising Pharma Holdings Inc., is $0.1545 per EA (NDC 16571011250), effective Jun 24, 2026.
How has the price of HYDROXYCHLOROQUINE 200 MG TAB changed over time?
Over the history we have for it, the NADAC for HYDROXYCHLOROQUINE 200 MG TAB has declined 13.6%. It has been tracked across 139 weekly CMS publications since Nov 1, 2023.
What are the highest and lowest recorded NADAC prices for HYDROXYCHLOROQUINE 200 MG TAB?
Since Nov 1, 2023, the NADAC for HYDROXYCHLOROQUINE 200 MG TAB has ranged from a low of $0.1399 (Nov 20, 2024) to a high of $0.1956 (Feb 14, 2024), with a median of $0.1622 per EA.
Are there cheaper alternatives to HYDROXYCHLOROQUINE 200 MG TAB?
7 NADAC-published products share the same active ingredient, strength, and dosage form as HYDROXYCHLOROQUINE 200 MG TAB, but none are currently priced below it.
Who manufactures HYDROXYCHLOROQUINE 200 MG TAB?
HYDROXYCHLOROQUINE 200 MG TAB (NDC 16571011250) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification